Clinical trial
Long-term Follow-up of Perioperative Dexmedetomidine-esketamine Combination and Transcranial Direct Current Stimulation for Prevention of Neurocognitive Complications in Older Patients After Non-cardiac Surgery
NCT07576543 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Follow-up of Perioperative Dexmedetomidine-esketamine Combination and Transcranial Direct Current Stimulation for Prevention of Neurocognitive Complications in Older Patients After Non-cardiac Surgery
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- December 31, 2031
- Enrollment
- 1,996 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive function, dexmedetomidine, esketamine, older patients, surgery, survival, transcranial direct current stimulation